These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34772415)

  • 1. Sequencing the CaSR locus in Pakistani stone formers reveals a novel loss-of-function variant atypically associated with nephrolithiasis.
    Ullah I; Ottlewski I; Shehzad W; Riaz A; Ijaz S; Tufail A; Ammara H; Mane S; Shril S; Hildebrandt F; Zahoor MY; Majmundar AJ
    BMC Med Genomics; 2021 Nov; 14(1):266. PubMed ID: 34772415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis.
    Vezzoli G; Terranegra A; Aloia A; Arcidiacono T; Milanesi L; Mosca E; Mingione A; Spotti D; Cusi D; Hou J; Hendy GN; Soldati L; ; Paloschi V; Dogliotti E; Brasacchio C; Dell'Antonio G; Montorsi F; Bertini R; Bellinzoni P; Guazzoni G; Borghi L; Guerra A; Allegri F; Ticinesi A; Meschi T; Nouvenne A; Lupo A; Fabris A; Gambaro G; Strazzullo P; Rendina D; De Filippo G; Brandi ML; Croppi E; Cianferotti L; Trinchieri A; Caudarella R; Cupisti A; Anglani F; Del Prete D
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3839-47. PubMed ID: 23864702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
    Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis.
    Amar A; Majmundar AJ; Ullah I; Afzal A; Braun DA; Shril S; Daga A; Jobst-Schwan T; Ahmad M; Sayer JA; Gee HY; Halbritter J; Knöpfel T; Hernando N; Werner A; Wagner C; Khaliq S; Hildebrandt F
    Hum Genet; 2019 Mar; 138(3):211-219. PubMed ID: 30778725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.
    Vezzoli G; Terranegra A; Arcidiacono T; Gambaro G; Milanesi L; Mosca E; Soldati L;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2245-52. PubMed ID: 20067903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients.
    Ferreira LG; Pereira AC; Heilberg IP
    Nephron Clin Pract; 2010; 114(2):c135-44. PubMed ID: 19887834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis.
    Majmundar AJ; Widmeier E; Heneghan JF; Daga A; Wu CW; Buerger F; Hugo H; Ullah I; Amar A; Ottlewski I; Braun DA; Jobst-Schwan T; Lawson JA; Zahoor MY; Rodig NM; Tasic V; Nelson CP; Khaliq S; Schönauer R; Halbritter J; Sayer JA; Fathy HM; Baum MA; Shril S; Mane S; Alper SL; Hildebrandt F
    Genet Med; 2023 Mar; 25(3):100351. PubMed ID: 36571463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
    Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-sensing receptor and calcium kidney stones.
    Vezzoli G; Terranegra A; Rainone F; Arcidiacono T; Cozzolino M; Aloia A; Dogliotti E; Cusi D; Soldati L
    J Transl Med; 2011 Nov; 9():201. PubMed ID: 22107799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
    Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
    Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
    Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis.
    Vezzoli G; Macrina L; Magni G; Arcidiacono T
    Urolithiasis; 2019 Feb; 47(1):23-33. PubMed ID: 30446806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population.
    Dershem R; Gorvin CM; Metpally RPR; Krishnamurthy S; Smelser DT; Hannan FM; Carey DJ; Thakker RV; Breitwieser GE;
    Am J Hum Genet; 2020 Jun; 106(6):734-747. PubMed ID: 32386559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the calcium-sensing receptor in disorders of abnormal calcium handling and cardiovascular disease.
    Toka HR; Pollak MR
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):494-501. PubMed ID: 24992569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasis.
    Livadariu E; Auriemma RS; Rydlewski C; Vandeva S; Hamoir E; Burlacu MC; Maweja S; Thonnard AS; Betea D; Vassart G; Daly AF; Beckers A
    Eur J Endocrinol; 2011 Aug; 165(2):353-8. PubMed ID: 21566074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
    Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals.
    Nissen PH; Rejnmark L
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):683-690. PubMed ID: 31433865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1).
    Boisen IM; Mos I; Lerche-Black EM; Juul A; Bräuner-Osborne H; Blomberg Jensen M
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32160303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.